Drug intelligence / Profile preview

Ningxing Yunke Ping Granules

Development stage: Unknown
Lead developer: Jinghua Pharmaceutical
Administration: Oral

Overview

Ningxing Yunke Ping Granules is a traditional Chinese medicine (TCM) product developed and manufactured by Jinghua Pharmaceutical Group. It is specifically formulated as oral granules for the prevention and treatment of motion sickness and vertigo. The product is a granule formulation of the Yunke Ping (晕可平) recipe, which is also available as a syrup. As a TCM, it utilizes a multi-component herbal approach to address the physiological imbalances leading to dizziness and nausea, although its specific molecular targets and pharmacological mechanisms are not defined in conventional Western medical terms. It is currently approved and marketed in China.

Brand names: NingxingYunke Ping
Other names: Ningxing Yunke PingYunke Ping Granules宁星晕可平颗粒晕可平颗粒

Beyond the preview

Go deeper on Ningxing Yunke Ping Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ningxing Yunke Ping Granules.

Explore the full profile